![]() Shared Decision Making and Communication.Scientific Discovery and the Future of Medicine.Health Care Economics, Insurance, Payment.Clinical Implications of Basic Neuroscience.Challenges in Clinical Electrocardiography.Age is considered at cancer diagnosis for affected individuals and at last follow-up for unaffected individuals. Age distribution graphs in the whole series of 6,902 male BRCA1 and BRCA2 PV carriers (A) and in the 1,376 affected male BRCA1 and BRCA2 PV carriers (B). Analyses restricted to affected individuals after omitting cancer diagnoses occurring more than 5 years prior to study recruitment.ĮFigure 1. Analysis restricted to the total cancers reported in the 1,376 affected male BRCA1/2 PV carriers within the CIMBA dataset and ORs in predicting BRCA2 PV carrier status.ĮTable 10. Cancer sites other than breast and prostate according to BRCA1/2 PV status and mean age at diagnosis.ĮTable 9. Analysis restricted to the first cancer diagnosis according to cancer site and BRCA1/2 PV in the 1,376 affected male carriers within CIMBA dataset and ORs in predicting BRCA2 PV carrier status.ĮTable 8. Cancer diagnosis in male BRCA1/2 PV carriers within the CIMBA dataset and ORs in predicting BRCA2 PV carrier status.ĮTable 7. Family history (FH) of male breast, female breast and prostate cancers in male BRCA1/2 PV carriers (regardless of cancer diagnosis) within the CIMBA dataset.ĮTable 6. ![]() ![]() ![]() Proband/Family member status in breast, prostate and other cancers in male BRCA1/2 PV carriers within the CIMBA dataset.ĮTable 5. Self-reported ethnicity in male BRCA1/2 PV carriers (regardless of cancer diagnosis) within the CIMBA dataset.ĮTable 4. Male BRCA1 and BRCA2 PV carriers by study group/country.ĮTable 2. BRCA1 and BRCA2 PV spectrum of male carriers included in this study.ĮTable 3. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |